Optimization of controlled release primaquine diphosphate tablets / Otimização da liberação de difosfato de primaquina em comprimidos de liberação controlada

AUTOR(ES)

Marcelo Dutra Duque

DATA DE PUBLICAÇÃO

2009

RESUMO

The objective of the present work was to produce primaquine diphosphate controlled release tablets based on hydrophilic polymers and use the mixture statistical experimental design (DOE) to optimize drug release. In selecting the components of the formulations, differential scanning calorimetry (DSC) were carried out to verify the compatibility between drug/excipients and evaluating flow properties of the powders by determining the angle of repose. The 20 formulations obtained in the experimental design contained mixtures of hydroxylpropylmethylcellulose of different degrees of viscosity (K15M, K4M and K100LV) and polyethylene glycol 4000 as polymers to control drug release. Tablets containing 30 mg of primaquine were produced by direct compression in a 9 mm single punch tablet press and were evaluated for hardness, friability, average weight, drug content and dissolution. The kinetics of drug release was studied applying Zero Order, Higuchi and Korsmeyer-Peppas models. DSC tests allowed verifying some kind of interaction between the drug and the excipients lactose and magnesium stearate. The values of angle of repose obtained demonstrated that the powders of the formulations presented good flow properties. The regression data obtained by the mathematical models failed to verify the influence of the mixture of polymers in the angle of repose of the powders and physical characteristics such as hardness, friability and average weight of the tablets. However, there was a significant influence of polymers composition in the dissolution of the tablets at intervals of 2, 4, 6 and 8 hours of testing. Most formulations showed anomalous transport as the mechanism of drug release. From these data and response surface plots generated by Design Expert® 6.0 software, it was possible to optimize the formulations by restricting the amount of each polymer to obtain a formulation with a double release mechanism, diffusion and relaxation of the hydrated matrix chains.

ASSUNTO(S)

planejamento experimental de mistura drug (planning) fámacos (planejamento) controlled release liberação controlada pharmacotechiques difosfato de primaquina farmacotécnica mixture experimental design primaquine diphosphate

Documentos Relacionados

• Otimização de comprimidos matriciais de liberação prolongada de teofilina aplicando o planejamento estatístico de mistura
• Matrizes de colágeno para liberação controlada de progesterona
• Planejamento e características de liberação de comprimidos de liberação controlada de cloridrato de metformina
• Formulation and optimization of controlled release mucoadhesive tablets of atenolol using response surface methodology
• Avaliação da Goma Guar no desenvolvimento de comprimidos matriciais de liberação controlada de teofilina